<table id="table6" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 6	Effect of Coadministered Drugs on Saquinavir Pharmacokinetics</caption>
<col align="left" span="1" valign="top" width="35%"></col>
<col align="left" span="1" valign="top" width="20%"></col>
<col align="center" span="1" valign="top" width="5%"></col>
<col align="center" span="1" valign="top" width="20%"></col>
<col align="center" span="1" valign="top" width="20%"></col>
<tbody>
<tr>
<td>
<content stylecode="bold">Coadministered Drug</content>
</td>
<td>
<content stylecode="bold">Saquinavir soft gel capsules</content>
</td>
<td>
<content stylecode="bold">N</content>
</td>
<td>
<content stylecode="bold">% Change for Saquinavir</content>
</td>
</tr>
<tr>
<td></td>
<td>
<content stylecode="bold">Dose</content>
</td>
<td></td>
<td>
<content stylecode="bold">AUC (95% CI)</content>
</td>
<td>
<content stylecode="bold">C<sub>max</sub> (95% CI)</content>
</td>
</tr>
<tr>
<td>Clarithromycin 500 mg bid × 7 days</td>
<td>1200 mg tid × 7 days</td>
<td>12V</td>
<td>↑177% (108-269%)</td>
<td>↑187% (105-300%)</td>
</tr>
<tr>
<td>Efavirenz 600 mg qd</td>
<td>1200 mg tid</td>
<td>13V</td>
<td>↓62%</td>
<td>↓50%</td>
</tr>
<tr>
<td>Indinavir 800 mg q8h × 2 days</td>
<td>1200 mg single dose</td>
<td>6V</td>
<td>↑364% (190-644%)</td>
<td>↑299% (138-568%)</td>
</tr>
<tr>
<td>Ritonavir 400 mg bid × 14 days</td>
<td>400 mg bid × 14 days<linkhtml href="#footnote-5">*</linkhtml>
</td>
<td>8V</td>
<td>↑121% (7-359%)</td>
<td>↑64%<linkhtml href="#footnote-6">†</linkhtml>
</td>
</tr>
<tr>
<td>Lopinavir/ritonavir<br/>Evidence from several clinical trials indicates that saquinavir concentrations achieved with saquinavir 1000 mg + lopinavir/ritonavir 400/100 mg BID are similar to those achieved following saquinavir/ritonavir 1000/100 mg BID.</td>
</tr>
<tr>
<td>
<content stylecode="bold">Coadministered Drug</content>
</td>
<td>
<content stylecode="bold">INVIRASE or INVIRASE/ritonavir</content>
</td>
<td>
<content stylecode="bold">N</content>
</td>
<td>
<content stylecode="bold">% Change for Saquinavir</content>
</td>
</tr>
<tr>
<td></td>
<td>
<content stylecode="bold">Dose</content>
</td>
<td></td>
<td>
<content stylecode="bold">AUC (95% CI)</content>
</td>
<td>
<content stylecode="bold">C<sub>max</sub> (95% CI)</content>
</td>
</tr>
<tr>
<td>Atazanavir 300 mg qd</td>
<td>1600/100 mg qd</td>
<td>18S</td>
<td>↑60%<br/>(16-122%)</td>
<td>↑42%<br/>(10-84%)</td>
</tr>
<tr>
<td>Fosamprenavir 700 mg bid</td>
<td>1000 mg bid/100 mg bid</td>
<td>18S</td>
<td>↓15%<br/>(-33% to 9%)</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td>Ritonavir 100 mg bid</td>
<td>1000 mg bid<linkhtml href="#footnote-7">‡</linkhtml>
</td>
<td>24S</td>
<td>↑1124%</td>
<td>↑1325%</td>
</tr>
<tr>
<td>Tenofovir 300 mg qd</td>
<td>1000 mg bid/100 mg bid</td>
<td>18S</td>
<td>↔<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td>Tipranavir 500 mg + ritonavir 200 mg bid</td>
<td>600 mg bid/100 mg bid</td>
<td>20S</td>
<td>↓76%<br/>(68-81%)<linkhtml href="#footnote-8">§</linkhtml>
</td>
<td>↓70%<br/>(60-77%)<footnoteref idref="tb6ft5"></footnoteref>
</td>
</tr>
<tr>
<td>Omeprazole 40 mg   qd × 5 days</td>
<td>1000/100 mg bid × 15 days</td>
<td>19V</td>
<td>↑82%<br/>(37-234%)<footnoteref idref="tb6ft5"></footnoteref>
</td>
<td>↑ 75%<br/>(31-234%)<footnoteref idref="tb6ft5"></footnoteref>
</td>
</tr>
<tr>
<td>Ketoconazole 200 mg/day</td>
<td>1000 mg bid/100 mg bid</td>
<td>20V</td>
<td>↔<footnoteref idref="tb6ft5"></footnoteref>
</td>
<td>↔</td>
</tr>
<tr>
<td>Rifabutin 150 mg q3d</td>
<td>1000 mg bid/100 mg bid</td>
<td>19V</td>
<td>↓13%<br/>(-31% to 9%)<footnoteref idref="tb6ft5"></footnoteref>
</td>
<td>↓15%<br/>(-32% to 7%)<footnoteref idref="tb6ft5"></footnoteref>
</td>
</tr>
<tr>
<td>↑	Denotes an average increase in exposure by the percentage indicated.</td>
</tr>
<tr>
<td>↓	Denotes an average decrease in exposure by the percentage indicated.</td>
</tr>
<tr>
<td>↔	Mean change &lt;10%</td>
</tr>
<tr>
<td>S	Subjects</td>
</tr>
<tr>
<td>V	Healthy Volunteers</td>
</tr>
<tr>
<td>
<br/>
</td>
</tr>
</tbody>
</table>